Tofacitinib Tablet, Film Coated
Product Images NDC 72205-139

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Tofacitinib (NDC 72205-139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tofacitinib-10mg-180s-cntr (Tofacitinib 10mg 180s Cntr)

Tofacitinib-10mg-180s-cntr (Tofacitinib 10mg 180s Cntr)
This is a description of Tofacitinib Tablets, with a recommended dosage of 10 mg for ulcerative colitis. The medication guide should be dispensed to each patient. Each film-coated tablet contains tofacitinib and should be stored at 20°C to 25°C. The tablets are manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals LLC. This information was issued in April 2026.*
FDA Label Image

Tofacitinib-10mg-28s-cntr (Tofacitinib 10mg 28s Cntr)

Tofacitinib-10mg-28s-cntr (Tofacitinib 10mg 28s Cntr)
This text provides information about a medication called tofacitinib in the form of film-coated tablets containing 10 mg of tofacitinib citrate. The dosage and usage instructions, including storage conditions, are included. It also mentions not to repackage the tablets and to keep them out of reach of children. The medication is recommended for Ulcerative Colitis. The manufacturer is identified as MSN Laboratories Private Limited in Telangana, India. The text also mentions dispensing a Medication Guide to each patient.*
FDA Label Image

Tofacitinib-10mg-60s-cntr (Tofacitinib 10mg 60s Cntr)

Tofacitinib-10mg-60s-cntr (Tofacitinib 10mg 60s Cntr)
This text appears to be a medication label for tablets containing 10 mg of tofacitinib, equivalent to 16.16 mg of Tofacitinib Citrate. It provides dosage and usage instructions, storage conditions, manufacturer information, and a caution to not repackage the tablets and to keep them out of reach of children. The tablets are recommended for Ulcerative Colitis.*
FDA Label Image

Tofacitinib-5mg-28s-cntr (Tofacitinib 5mg 28s Cntr)

Tofacitinib-5mg-28s-cntr (Tofacitinib 5mg 28s Cntr)
The text provides information about a medication called Tofacitinib, where each film-coated tablet contains 5g of the active ingredient. The dosage and use details can be found in the accompanying prescribing information. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and should not be repackaged. It is important to keep the medication out of reach of children. The manufacturer is mentioned as MSN Laboratories Private Limited located in Telangana, India. The medication is being distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ.*
FDA Label Image

Tofacitinib-5mg-60s-cntr (Tofacitinib 5mg 60s Cntr)

Tofacitinib-5mg-60s-cntr (Tofacitinib 5mg 60s Cntr)
Each film-coated tablet contains 5 mg of tofacitinib. Store tablets at 20°C to 25°C. Dispense the medication guide to each patient. Manufactured by MSN Laboratories Private Limited in India and distributed by Novadoz Pharmaceuticals in Piscataway, NJ. Do not repackage, keep out of the reach of children.*
FDA Label Image

Tofacitinib-figure-01 (Tofacitinib Figure 01)

FDA Label Image

Tofacitinib-figure-02 (Tofacitinib Figure 02)

FDA Label Image

Tofacitinib-figure-03 (Tofacitinib Figure 03)

FDA Label Image

Tofacitinib-figure-04 (Tofacitinib Figure 04)

FDA Label Image

Tofacitinib-figure-05 (Tofacitinib Figure 05)

FDA Label Image

Tofacitinib-figure-06 (Tofacitinib Figure 06)

FDA Label Image

Tofacitinib-figure-07 (Tofacitinib Figure 07)

FDA Label Image

Tafacitinib-structure (Tofacitinib Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.